Overview
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors
Status:
Unknown status
Unknown status
Trial end date:
2018-04-01
2018-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to use ambulatory blood pressure monitors to investigate whether enalapril is superior to lisinopril in managing nocturnal hypertension in patients with resistant hypertension currently treated with daytime angiotensin converting enzyme inhibitors.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Memorial Health University Medical CenterTreatments:
Angiotensin-Converting Enzyme Inhibitors
Enalapril
Enalaprilat
Enzyme Inhibitors
Lisinopril
Criteria
Inclusion Criteria:- Patients with clinic blood pressure > 140/90 mm Hg on 3 antihypertensives or clinic
blood pressure < 140/90 mm Hg on 4 antihypertensives
- Currently treated with an angiotensin converting enzyme inhibitor
Exclusion Criteria:
- Chronic kidney disease (CKD) stage 4 or worse
- Pheochromocytoma
- Unstable cardiovascular disease Stroke, Transient Ischemic Attack, Unstable Angina, or
Myocardial infarction in the last 30 days
- Hyperaldosteronism
- Current pregnancy
- Shift worker at night
- Presenting blood pressure > 180/110 mm Hg